RxDoctor Payments DataLook up a doctor →

Basil Hassan, MD

Family Medicine · West Des Moines, IANPI 1932180437

Payments from drug & device makers

$13,737in general payments, 2019–2025

Across 766 payments — averaging $17.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Pfizer$1K
  • Johnson & Johnson$1K
  • Amgen$878
  • Boehringer Ingelheim$878
  • AstraZeneca$834
  • plus $7K from 51 others

What the payments were for

  • Food & beverage$13,45798%
  • Education$2802%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)115$1,982
Pfizer98$1,315
Johnson & Johnson35$1,135
Amgen60$878
Boehringer Ingelheim50$878
AstraZeneca19$834
Astellas Pharma US Inc34$576
Novartis38$531
Lilly USA, LLC35$492
Teva Pharmaceuticals USA, Inc.15$470
Novo Nordisk31$469
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC22$432
Otsuka America Pharmaceutical, Inc.14$319
Merck19$278
Bayer14$245
Lundbeck LLC13$230
Mylan Specialty L.p.12$202
Collegium Pharmaceutical, Inc.15$189
Almatica Pharma LLC8$161
Nestle Healthcare Nutrition Inc.10$147
Takeda Pharmaceuticals U.S.A., Inc.9$138
E.r. Squibb & Sons, L.L.C.7$126
Sunovion Pharmaceuticals Inc.7$124
Axsome Therapeutics, Inc.1$120
Exact Sciences6$116
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)5$95
Phathom Pharmaceuticals, Inc.5$92
Amarin Pharma, Inc.6$88
Idorsia Pharmaceuticals US Inc6$87
Biohaven Pharmaceutical Holding Company Ltd.4$79
GSK4$73
Medtronic2$69
Adlon Therapeutics L.p.3$57
Biogen3$54
Xeris Pharmaceuticals, Inc.3$51
Eisai Inc.4$49
Acadia Pharmaceuticals Inc3$47
Kaleo, Inc.3$46
Kowa Pharmaceuticals America, Inc.3$44
Melinta Therapeutics, LLC3$42
UCB, Inc.2$38
Paratek Pharmaceuticals, Inc.2$36
Neurocrine Biosciences, Inc.2$34
Aimmune Therapeutics, Inc.2$31
Shire North American Group Inc2$28
Otsuka Pharmaceutical Development & Commercialization, Inc.1$25
Vertex1$20
Brainsway USA Inc1$20
Biohaven Pharmaceuticals, Inc.1$19
Supernus Pharmaceuticals, Inc.1$19
Kerecis Limited1$18
Abbott1$17
Neos Therapeutics, LP1$17
Verona Pharma, Inc.1$15
Genentech USA, Inc.1$14
Daiichi Sankyo Inc.1$14
Ultragenyx Pharmaceutical Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,737 in reported general payments places this provider in the 95th percentile of 1,357 family medicine providers in Iowa.

See all family medicine providers in Iowa

Medicare billing

Part B allowed, 2024
$60,030
Medicare patients
189
Services billed
787

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban363$106,303
OtezlaApremilast27$63,737
JardianceEmpagliflozin74$58,356
TrulicityDulaglutide59$42,233
VelphoroSucroferric Oxyhydroxide17$25,876
XareltoRivaroxaban76$24,997
JanuviaSitagliptin Phosphate44$21,075
MyrbetriqMirabegron56$17,425
Fluticasone-SalmeterolFluticasone Propion/Salmeterol66$13,258
JanumetSitagliptin Phos/Metformin Hcl28$12,123
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$11,187
Bydureon BciseExenatide Microspheres12$9,979
Atorvastatin Calcium677$9,607
Gabapentin410$8,908
Lantus SolostarInsulin Glargine,hum.Rec.Anlog99$8,522

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Prempro$1,315$109,036375 claims
Boehringer IngelheimJardiance, Spiriva Respimat$878$64,52985 claims
AmgenOtezla$878$63,73727 claims
Lilly USA, LLCTrulicity$492$42,23359 claims
MerckJanuvia, Janumet, Dulera$278$38,91394 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta$73$30,07662 claims
Johnson & JohnsonXarelto$1,135$24,99776 claims
Astellas Pharma US IncMyrbetriq$576$17,42556 claims
AbbVieRestasis$1,982$6,89120 claims
NovartisEntresto$531$5,46831 claims
AstraZenecaSymbicort$834$3,90116 claims
Almatica Pharma LLCSertraline Hcl$161$2,804200 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,357 family medicine providers in Iowa.

Other family medicine in West Des Moines

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →